Onc.AI

About

Onc.AI is a digital health company based in San Carlos, California, founded in 2020. The company focuses on AI-powered solutions to enhance decision-making in oncology by analyzing various data types, including diagnostic imaging, electronic medical records, and genomic information. Onc.AI develops AI models that predict clinical outcomes, particularly for metastatic lung cancer patients undergoing PD-1 immunotherapy. Their clinical decision support platform integrates insights from multiple data sources to aid oncologists in personalized treatment planning. The company is actively working on expanding its AI solutions across oncology, genomics, proteomics, and radiomics to improve diagnostic and therapeutic applications. With a team of 20-50 employees, Onc.AI has raised $33 million in funding, including a recent $2 million grant.